Literature DB >> 14617240

Improvement in quality of colorectal cancer pathology reporting with a standardized proforma--a comparative study.

G C Beattie1, T K McAdam, S Elliott, J M Sloan, S T Irwin.   

Abstract

BACKGROUND: Histopathological evaluation is a critical component in the management of patients with colorectal cancer (CRC). It is the single most powerful prognostic indicator in CRC and determines if adjuvant chemotherapy is indicated. The aim of this study was to assess if the introduction of a comprehensive standardized pathology proforma improved the quality of histopathology reporting.
METHODS: A standardized pathology proforma, based on the 1996 minimum dataset for colorectal histopathology reporting, was introduced in our pathology department in 1998. Pathology reports for all colonic resection specimens for 1996 (n = 85) and 2000 (n = 86) were identified, retrieved and entered on to database. Comparison was made with the minimum dataset published in the 1996 guidelines for the management of colorectal cancer.
RESULTS: Demographic details were complete in all cases. Clinical data was incomplete in 57 (67%) patients in 1996 and 63 (73%) in 2000 (ns; chi2). There were 24 (28%) (7 Abdomino-perineal resections (APER)) and 40 (47%) (17 APER's) rectal specimens for 1996 and 2000, respectively. The presence or absence of pathological background abnormalities were commented on in 18 (21%) reports in 1996 and 80 (93%) reports in 2000 (P < 0.01; Fishers exact test (Fisher)). Histological differentiation was commented on in 73 (86%) and 86 (100%) in 1996 and 2000, respectively (P < 0.01; Fisher). Dukes' stage was stated in 33 (39%) reports in 1996 and 86 (100%) in 2000 (P < 0.01; Fisher) but Dukes' stage was calculable in 84 (99%) in 1996 and 86 reports (100%) for 2000 (ns; Fisher). The apical node was commented on in 34 (40%) reports in 1996 and 85 (99%) reports in 2000 (P < 0.01; Fisher). The median (IQR) number of nodes assessed in 1996 was 8 (5-12) compared to 12 (8-17) in 2000 (P < 0.001; Mann-Whitney (MW)). Complete resection was mentioned in 74 (87%) reports in 1996 and 86 (100%) in 2000 (P < 0.01; Fisher). Regarding rectal specimens, the circumferential resection margin (CRM) was commented on in 19 of 24 specimens in 1996 and 38 of 40 specimens in 2000 (ns; Fisher). Relationship to the peritoneal reflection was commented on in 1 (1%) rectal specimen in 1996 and 30 (35%) in 2000 (P < 0.001; Fisher).
CONCLUSION: The introduction of a standardized proforma for reporting CRC resection specimens improves the quality of histopathological reporting. This aids decision-making regarding adjuvant chemotherapy or radiotherapy and further surveillance.

Entities:  

Mesh:

Year:  2003        PMID: 14617240     DOI: 10.1046/j.1463-1318.2003.00466.x

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  12 in total

1.  Assessing outcomes following surgery for colorectal cancer using quality of care indicators.

Authors:  Omar Vergara-Fernandez; Carol J Swallow; J Charles Victor; Brenda I O'Connor; Robert Gryphe; Helen M MacRae; Zane Cohen; Robin S McLeod
Journal:  Can J Surg       Date:  2010-08       Impact factor: 2.089

2.  Health System-Level Factors Influence the Implementation of Complex Innovations in Cancer Care.

Authors:  Robin Urquhart; Lois Jackson; Joan Sargeant; Geoffrey A Porter; Eva Grunfeld
Journal:  Healthc Policy       Date:  2015-11

3.  The impact of standard protocol implementation on the quality of colorectal cancer pathology reporting.

Authors:  Peter Ihnát; Patricie Delongová; Jaroslav Horáček; Lucia Ihnát Rudinská; Petr Vávra; Pavel Zonča
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

4.  Factors related to the implementation and use of an innovation in cancer surgery.

Authors:  R Urquhart; J Sargeant; G A Porterm
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

Review 5.  Controversies in the pathological assessment of colorectal cancer.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Surgeons' Evaluation of Colorectal Cancer Resections Against Standard HPE Protocol-Auditing the Surgeons.

Authors:  Ismail Sagap; Abdel Latif K Elnaim; Imtiaz Hamid; Isa M Rose
Journal:  Indian J Surg       Date:  2011-02-15       Impact factor: 0.656

7.  Evaluating the quality of colorectal cancer care in the state of Florida: results from the Florida Initiative for Quality Cancer Care.

Authors:  Erin M Siegel; Paul B Jacobsen; Mokenge Malafa; William Fulp; Michelle Fletcher; Ji-Hyun Lee; Jesusa Corazon R Smith; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; David Shibata
Journal:  J Oncol Pract       Date:  2012-06-12       Impact factor: 3.840

8.  Exploring the interpersonal-, organization-, and system-level factors that influence the implementation and use of an innovation-synoptic reporting-in cancer care.

Authors:  Robin Urquhart; Geoffrey A Porter; Eva Grunfeld; Joan Sargeant
Journal:  Implement Sci       Date:  2012-03-01       Impact factor: 7.327

Review 9.  Quality assurance in pathology in colorectal cancer screening and diagnosis—European recommendations.

Authors:  Phil Quirke; Mauro Risio; René Lambert; Lawrence von Karsa; Michael Vieth
Journal:  Virchows Arch       Date:  2011-01       Impact factor: 4.064

10.  Does geography influence the treatment and outcomes of colorectal cancer? A population-based analysis.

Authors:  Ramzi M Helewa; Donna Turner; Debrah Wirtzfeld; Jason Park; David Hochman; Piotr Czaykowski; Harminder Singh; Emma Shu; Lin Xue; Andrew McKay
Journal:  World J Surg Oncol       Date:  2013-06-17       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.